Effect of self-efficacy and social support on adherence to antihypertensive drugs

Pharmacotherapy

Volumn 30, Issue 5, 2010, Pages 432-441

  Criswell, Thomas J ^a   Weber, Cynthia A ^a   Xu, Yinghui ^b   Carter, Barry L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Adherence; Hypertension; Pharmacist management; Research methods; Self efficacy; Social support; Team care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PATIENT COMPLIANCE; SCORING SYSTEM; SELF CONCEPT; SOCIAL SUPPORT; STRUCTURED QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COOPERATIVE BEHAVIOR; EDUCATION, MEDICAL, CONTINUING; EFFECT MODIFIERS (EPIDEMIOLOGY); FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; SELF EFFICACY; SOCIAL SUPPORT; STATISTICS AS TOPIC; TIME FACTORS; YOUNG ADULT;

EID: 77951732947     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.5.432     Document Type: Article

References (38)

1. Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension 2004;44:602-8.
2. MacMahon SW, Cutler JA, Neaton JD, et al. Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J Hypertens 1986;4(suppl):S14-17.
3. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981-97.
4. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52.
5. Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed 2007;9(3):58.
6. Weber CA, Leloux MR, Carter BL, Farris KB, Xu Y. Reduction in adverse symptoms as blood pressure becomes controlled. Pharmacotherapy 2008;28:1104-14.
7. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol 2003;56:520-9.
8. Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens 2008;10(1 suppl 1):20-6.
9. Kressin NR, Wang F, Long J, et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med 2007;22:768-74.
10. Ross SD, Akhras KS, Zhang S, Rozinsky M, Nalysnyk L. Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis. Pharmacotherapy 2001;21:940-53.
11. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000;20:941-9.
12. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis 2004;14:3-12.
13. Morisky DE, DeMuth NM, Field-Fass M, Green LW, Levine DM. Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q 1985;12:35-50.
14. Doherty WJ, Schrott HG, Metcalf L, Iasiello-Vailas L. Effect of spouse support and health beliefs on medication adherence. J Fam Pract 1983;17:837-41.
15. Bandura A. Self-efficacy in changing societies. New York: Cambridge University Press, 1995.
16. Bandura A, Jeffery RW, Wright CL. Efficacy of participant modeling as a function of response induction aids. J Abnorm Psychol 1974;83:56-64.
17. Bandura A, Jourden EJ. Self-regulatory mechanisms governing the impact of social comparison on complex decision making. J Pers Soc Pyschol 1991;60:941-51.
18. Bandura A, Reese L, Adams NE. Microanalysis of action and fear arousal as a function of differential levels of perceived self-efficacy. J Pers Soc Psychol 1982;43:5-21.
19. De Geest S, Abraham I, Gemoets H, Evers G. Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development. J Adv Nurs 1994;19:233-8.
20. Sarason IG, Sarason BR, Shearin EN. Social support as an individual difference variable: its stability, origins, and relational aspects. J Pers Socl Psychol 1982;50:845-55.
21. Carter BL, Bergus GR, Dawson JD, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008;10:260-71.
22. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169:1996-2002.
23. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
24. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
25. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002;288:2421-31.
26. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 2005;45:142-61.
27. National Heart, Lung, and Blood Institute. Your guide to lowering blood pressure. Available from http://www.nhlbi.nih.gov/health/dci/Diseases/Hbp/HBP- WhatIs.html. Accessed May 22, 2003.
28. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist comanagement of hypertension. PharmWorld Sci 2008;30:128-35.
29. Degli Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002;16:439-44.
30. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 2002;24:1347-57.
31. Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm 2009;66:657-64.
32. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006;296:2563-71.
33. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a metaanalysis. Arch Intern Med 2009;169:1748-55.
34. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association professional education committee of the council for high blood pressure research. Circulation 2008;117:e510-26.
35. Garg JP, Elliott WJ, Folker A, Izhar M, Black HR. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 2005;18(5 pt 1):619-26.
36. Carter BL, Doucette WR, Franciscus CL, Ardery G, Kluesner KM, Chrischilles EA. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy 2010;30:228-35.
37. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348-54.
38. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009;43:413-22.